Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis

Expert Review of Molecular Diagnostics
Elaine Mardis, Claire Raison

Abstract

Elaine Mardis, co-director of the Genome Institute at Washington University (St Louis, MO, USA), is an expert in genome sequencing technologies, having been involved in developing and automating the methods employed in sequencing the human genome. Professor Mardis has made key contributions to the Human Genome Project and more recently, to the field of cancer genomics, including work in The Cancer Genome Atlas. Her current research interests lie in next-generation sequencing and analysis of cancer genomes and the translation of these findings to support therapeutic decision making.

References

Nov 20, 2014·Nature·Dejan JuricMaurizio Scaltriti
Nov 28, 2014·Nature·Matthew M GubinRobert D Schreiber

❮ Previous
Next ❯

Citations

Jan 26, 2018·European Journal of Human Genetics : EJHG·Patricia MarinoUNKNOWN NGSEco Group:

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

Academic Medicine : Journal of the Association of American Medical Colleges
Alison Whelan
Missouri Medicine
C Fischer
The New England Journal of Medicine
Howard J Jacob
© 2021 Meta ULC. All rights reserved